Product name:4-[(4-Methylpiperazin-1-yl)methyl]benzoicaciddihydrochloride

Alias:4-[(4-Methylpiperazin-1-yl)methyl]benzoicaciddihydrochloride;4-[(4-Methylpiperazin-1-yl)methyl]benzoicaciddihydrochloride0.5hydrate;4-[(4-METHYLPIPERAZIN-1-YL)METHYL] BENZOICACIDDIHYDROCHLORIDEHEMIHYDRATE;4-[(4-METHYL-1-PIPERAZINYL)METHYL]BENZOICACIDDIHYDROCHLORIDEHEMIHYDRATE;4-[(4-Methyl-1-piperazinyl)methyl]benzoicaciddihydrochloride;4-[(4-Methyl-1-piperaziny)methyl]benzoicacid; 4-[(4-methyl-1-piperizino)methyl]benzoicaciddihydrochloridehemihydrate;benzoicaciddihydrochloride

CAS No.:106261-49-8

Molecular formula: C13H20Cl2N2O2

Molecular weight: 307.22

Structural formula:

Uses: Imatinib is an oral drug for the treatment of adult patients with Philadelphia chromosome (Ber-Abl)-positive chronic myeloid leukemia (CML) in the blast phase, accelerated phase, and chronic phase after failure of interferon therapy.